June 12, 2018

How can we reduce heart failure rates after heart attacks?

Patients who have heart attacks frequently progress to heart failure, which has a five-year mortality of 40-50%1, which is more deadly than cancer. The size of the heart attack (amount of damage or infarct size) is the single most important factor in determining future progression to heart failure. RIC has been shown to reduce infarct size in multiple heart attack trials, but how does that translate into heart failure reduction?
June 1, 2018

How can a cardioprotective treatment help protect the kidneys?

Contrast media used in cardiac procedures is toxic to the kidneys, especially in patients with chronic kidney disease. The appearance of acute kidney injury, even if transient, predicts worse cardiac outcomes and higher mortality in affected patients.
Get autoRIC®